Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA Centaur PAPPA and BhCG Assays
Serum Sample Collection to Determine Analytical Performance Characteristics of the ADVIA CENTAUR® PREGNANCY ASSOCIATED PLASMA PROTEIN A and ADVIA Centaur® Free Beta Human Chorionic Gonadotropin ASSAYS
Sponsor: Axis Shield Diagnostics Ltd
Listed as NCT03629795, this observational or N/A phase trial focuses on Trisomy 13 in Fetus and Trisomy 18 in Fetus and remains completed. Sponsored by Axis Shield Diagnostics Ltd, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Sep 2018 — Nov 2020 [monthly]
Completed
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Axis Shield Diagnostics Ltd
- The Clinical Trial Company
For direct contact, visit the study record on ClinicalTrials.gov .